"The price of greatness is responsibility." Sir Winston Churchill


Search the IBPA



IBPA Issues
About IBPA
IBPA Constitution
FAQ-s
IBPA Events
Individual Membership
Institutional Membership
IBPA Forums / Groups
Cooperation with IBPA
Links

Publications
IBPA Careers Newsletter
Past Issues
Industry Publications
Promote Yourself within the Industry
Submit Your Article

Career Center: Employers
Job Posting
Free Resume Database
Volunteers Database

Career Center: Job Seekers
Now Hiring
Submit Resume
Career Training
Nurses Careers in Biopharm
Scholarship Programs
Internship Programs
Resume Editing & Interview Coaching
Volunteer for the Industry
Download IBPA Career Info Brochure

Industry Directories and Listings
Pharmaceutical Companies
Contract Research Organizations
Professional Associations
Recruiters and Staffing Agencies
Clinical Research Centers
Consulting Companies
Education & Training Institutions
Jobs and Resume Searching Directories
Research and Development Companies
List Your Company

Investor's Center
Offers
Calls

Contact IBPA
US Chapter
Canadian Chapter
European Chapter
Asian Chapter

Start Your Career in Biotech with IBPA Scholarship Programs
Untitled Document



Subscribe to our "Careers in the Biopharmaceutical Industry" newsletter:

Name*:

Email*:

City:

Country:

Phone:

To unsubscribe, click here

 

 

Alexander S. Wiener

From Wikipedia, the free encyclopedia

 

Dr. Alexander S. Wiener (1907-1976), a lifelong resident of New York City, was recognized internationally for his contributions to science. He was an outstanding leader in the fields of Forensic Medicine, Serology, and Immunogenetics. His pioneer work led to discovery of the Rh factor in 1937, along with Dr. Karl Landsteiner, and subsequently to the development of exchange transfusion methods that saved the lives of countless infants with hemolytic disease of the newborn. He received a Lasker Award for his achievement.

At first, Dr. Wiener and Dr. Lansteiner did not understand the full significance of their discovery. They were enagaged in identifying a range of factors, such as the M factor, which proved to have much less significance. Dr. Wiener named the Rh factor after the Rhesus monkeys used as test subjects. However, by the time he and Dr. Landsteiner published in 1940, Dr. Wiener was able to demonstrate the role of Rh sensitization as a cause of intragroup hemalytic reactions, thus increasing the safety of blood transfusions.

Also, in conjunction with Dr. Phillip Levine's separate work which helped identify the Rh factor as a major cause of erythroblastosis fetalis, or Rh disease, he was able to help solve a major cause of infant fatality. He created the first medical procedure to combat the problem, which he called an exchange transfusion. It consisted of a complete blood transfusion for the affected baby. The method was further refined by Dr. Harry Wallerstein, a transfusionist.

Since then, less extreme methods have been found to deal with erythroblastosis fetalis. However, at the time, the procedure was able to save over 200,000 lives.

A lot of Dr. Wiener's later work involved examining the genetics of the Rh factor. In the process, he became embroiled in controversy, as an alterate theory (CDE), which was somewhat simpler to understand, was also proposed. Although Dr. Wiener's theories on the genetics of the Rh factor have ultimately proven correct, there are still many who have adopted the CDE notations, because of their greater simplicity.

Dr. Wiener's theory is that Rh inheritance is controlled as follows:

There is one Rh locus at which occurs one Rh gene, but this gene has multiple alleles. For example, one gene R1 produces one agglutinogen (antigen) Rh1 which is composed of three "factors": rh', Rh(o), and hr' '. The three factors are analogous to C, D, and e respectively in the CDE nomenclature. The d gene does not exist in Wiener's theory, and, in fact, has been proven not to exist at all.

Dr. Wiener spent most of his career working at the Brooklyn Jewish Hospital. He also helped the police with many investigations, using his identifications of blood types to help solve crimes. His original intent was to find as many factors in blood to make blood as identifiable as a fingerprint. Of course, with modern DNA technology, that is now possible.

[edit]

 

References

  • Alexander S. Wiener Rh-Hr Blood Types
  • Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940;43:223-224.
  • Addine Erskine The Principles and Practices of Blood Grouping
  • Pauline M. H. Mazumdar Species and Specifcity
  • David R. Zimmerman, Rh: The Intimate History of a Disease and Its Conquest Macmillan (1973) ISBN 0026335301.



External links




Learn More About the Biopharmaceutical Industry and Clinical Research:


Category:


Powered by Wikipedia, the free encyclopedia. Articles were developed by IBPA volunteers.

A

B

C

D

E

F

G

I

K

L

M

N

P

Q

R

S

T


©2004 International Biopharmaceutical Association Inc., all rights reserved
Privacy Policy - Terms of Use

Google